Information Hub

Event
Medical
Corporate
Corporate
2018-12-06

ACT Genomics joins TMB Harmonization Project

TMB (tumor mutational burden) is an important biomarker for predicting immunotherapy response. The project convened major diagnostics company to standardize TMB calculation across tests. ACT Genomics is the only non-US company participating in the project

Published:

Author(s):

Corporate
2018-10-09

ACT Genomics Finished A New Fundraising Round in The Wave of Medical Market Growth

Global medical market grows at the rate of 7% steadily, and the compound annual growth rate is expected to reach 19% in 2030 with the explosive potential in precision medicine. ACT Genomics Holdings Company Limited focusing on cancer genomic profiling se

Published:

Taipei

Author(s):

Medical
2018-09-21

Finding New Drug through Cancer Genomic Profiling is The New Option for Cancer Treatment

A patient with advanced colon cancer was eager to find new drugs through comprehensive cancer genomic profiling, and two targeted drugs were used to control cancer growth.

Published:

Taipei

Author(s):

PChome online

Event
2018-09-06

Hong Kong is Actively Building Technology Platform

Mr. Eddie Liu, Managing Director of ACT Genomics Hong Kong was invited to give a talk to share the experience of ACT Genomics expanding from Taiwan to Hong Kong.

Published:

Taipei

Author(s):

China Times

Event
2018-08-27

The Trend Toward Intelligent Biomedical Industry – Taipei Biotechnology Industry Summit

The Taipei Biotechnology Industry Summit was held in Taipei on August 27th by Department of Economic Development, Taipei City Government. ACT Genomics CEO, Dr. Hua-Chien Chen shared ”cancer precision medicine and its clinical application”. Dr. Chen said

Published:

Taipei

Author(s):

Global Monthly

Event
2018-06-15

ACT Genomics Shared Cutting-Edge Technology in Taiwan Bio Forum

ACT Genomics was invited to Taiwan Bio Forum, which was held in Harvard Medical School in USA this year. As the first speaker, ACT Genomics shared cutting-edge technology application in cancer management and precision medicine.

Published:

Author(s):

Economic Daily News

Event
2018-06-06

Taiwan Bio Forum on digital transformation in healthcare

ACT Genomics is honoured to introduce precision medicine in Taiwan Bio Forum co-organized by The Development Center for Biotechnology (DCB) and Monte Jade Science and Technology Association of New England (MJNE) in Boston.

Published:

Author(s):

United Daily

Corporate
2018-06-05

Clinical Utility of and Access to Cancer Molecular Diagnostics in Asia

ACT Genomics Singapore is honoured to be featured in Asia-Pacific Biotech News (APBN) magazine June 2018 issue, with features article titled “Clinical Utility of and Access to Cancer Molecular Diagnostics in Asia”. Dr Allen Lai & Dr Liisa sharing how mole

Published:

Author(s):

Event
2018-05-10

Gene Online reports on 2018 TJCC (Taiwan Joint Cancer Conference)

Dr. Sadakatsu Ikeda, ACTG's guest speaker at TJCC, shared his insights on when to use mono-therapy, combine-therapy, and immuno-therapy, using genomic profiling and tumor mutation burden (TMB) as guidance.

Published:

Taipei

Author(s):

Gene Online

Corporate
2018-05-01

The new biomedical winner in Southeast Asia

Dr. Allen Lai is honoured to be featured in Taiwan Trade Insight magazine, sharing his insight and vision on comprehensive genomic profiling in Southeast Asia market.

Published:

Author(s):